Matches in SemOpenAlex for { <https://semopenalex.org/work/W2274080969> ?p ?o ?g. }
- W2274080969 endingPage "2880" @default.
- W2274080969 startingPage "2877" @default.
- W2274080969 abstract "Vision impairment and blindness create a significant impact on quality of life and loss of productivity. Health care expenditures for vision problems, including direct medical costs and indirect costs for support services and loss of productivity, amount to $139 billion annually. It is projected that by 2020, five million people will have visual impairment due to age related macular degeneration and diabetic macular edema. VEGF inhibitor therapy has been shown to be a cost-effective treatment for age related macular degeneration and diabetic macular edema that has reduced the incidence of vision loss and can reduce the associated economic and societal cost." @default.
- W2274080969 created "2016-06-24" @default.
- W2274080969 creator A5031936679 @default.
- W2274080969 creator A5039480001 @default.
- W2274080969 creator A5044785404 @default.
- W2274080969 creator A5053747667 @default.
- W2274080969 creator A5071258270 @default.
- W2274080969 creator A5087356769 @default.
- W2274080969 creator A5091084487 @default.
- W2274080969 date "2016-02-25" @default.
- W2274080969 modified "2023-10-12" @default.
- W2274080969 title "Economic and Quality of Life Benefits of Anti-VEGF Therapy" @default.
- W2274080969 cites W1481978003 @default.
- W2274080969 cites W1573591982 @default.
- W2274080969 cites W1786285359 @default.
- W2274080969 cites W1786299986 @default.
- W2274080969 cites W1789824814 @default.
- W2274080969 cites W1935342590 @default.
- W2274080969 cites W1972305015 @default.
- W2274080969 cites W1973172428 @default.
- W2274080969 cites W1982933555 @default.
- W2274080969 cites W2013520033 @default.
- W2274080969 cites W2018888303 @default.
- W2274080969 cites W2042363066 @default.
- W2274080969 cites W2043631987 @default.
- W2274080969 cites W2046402035 @default.
- W2274080969 cites W2048884183 @default.
- W2274080969 cites W2053282839 @default.
- W2274080969 cites W2068742492 @default.
- W2274080969 cites W2071387961 @default.
- W2274080969 cites W2079794035 @default.
- W2274080969 cites W2083043469 @default.
- W2274080969 cites W2085442615 @default.
- W2274080969 cites W2091467743 @default.
- W2274080969 cites W2094945298 @default.
- W2274080969 cites W2107826392 @default.
- W2274080969 cites W2124415048 @default.
- W2274080969 cites W2140181275 @default.
- W2274080969 cites W2148636504 @default.
- W2274080969 cites W2158029475 @default.
- W2274080969 cites W2161487737 @default.
- W2274080969 cites W2260681771 @default.
- W2274080969 cites W2315243839 @default.
- W2274080969 cites W2316516002 @default.
- W2274080969 cites W2332699701 @default.
- W2274080969 doi "https://doi.org/10.1021/acs.molpharmaceut.5b00775" @default.
- W2274080969 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/26836112" @default.
- W2274080969 hasPublicationYear "2016" @default.
- W2274080969 type Work @default.
- W2274080969 sameAs 2274080969 @default.
- W2274080969 citedByCount "21" @default.
- W2274080969 countsByYear W22740809692017 @default.
- W2274080969 countsByYear W22740809692018 @default.
- W2274080969 countsByYear W22740809692020 @default.
- W2274080969 countsByYear W22740809692021 @default.
- W2274080969 countsByYear W22740809692022 @default.
- W2274080969 countsByYear W22740809692023 @default.
- W2274080969 crossrefType "journal-article" @default.
- W2274080969 hasAuthorship W2274080969A5031936679 @default.
- W2274080969 hasAuthorship W2274080969A5039480001 @default.
- W2274080969 hasAuthorship W2274080969A5044785404 @default.
- W2274080969 hasAuthorship W2274080969A5053747667 @default.
- W2274080969 hasAuthorship W2274080969A5071258270 @default.
- W2274080969 hasAuthorship W2274080969A5087356769 @default.
- W2274080969 hasAuthorship W2274080969A5091084487 @default.
- W2274080969 hasConcept C118487528 @default.
- W2274080969 hasConcept C118552586 @default.
- W2274080969 hasConcept C119767625 @default.
- W2274080969 hasConcept C120665830 @default.
- W2274080969 hasConcept C121332964 @default.
- W2274080969 hasConcept C121955636 @default.
- W2274080969 hasConcept C133425853 @default.
- W2274080969 hasConcept C134018914 @default.
- W2274080969 hasConcept C141071460 @default.
- W2274080969 hasConcept C144133560 @default.
- W2274080969 hasConcept C145096142 @default.
- W2274080969 hasConcept C159110408 @default.
- W2274080969 hasConcept C160735492 @default.
- W2274080969 hasConcept C162324750 @default.
- W2274080969 hasConcept C204983608 @default.
- W2274080969 hasConcept C2776403814 @default.
- W2274080969 hasConcept C2776694085 @default.
- W2274080969 hasConcept C2777802072 @default.
- W2274080969 hasConcept C2779829184 @default.
- W2274080969 hasConcept C2779951463 @default.
- W2274080969 hasConcept C2780929884 @default.
- W2274080969 hasConcept C2781100027 @default.
- W2274080969 hasConcept C2781372952 @default.
- W2274080969 hasConcept C2985127711 @default.
- W2274080969 hasConcept C3019354653 @default.
- W2274080969 hasConcept C50522688 @default.
- W2274080969 hasConcept C555293320 @default.
- W2274080969 hasConcept C61511704 @default.
- W2274080969 hasConcept C6964187 @default.
- W2274080969 hasConcept C71924100 @default.
- W2274080969 hasConceptScore W2274080969C118487528 @default.
- W2274080969 hasConceptScore W2274080969C118552586 @default.
- W2274080969 hasConceptScore W2274080969C119767625 @default.